Usana Health Sciences (USNA) Reports Strong Q2 Results; Raises FY12 Outlook
Usana Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.11, $0.19 better than the analyst estimate of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
